Market Overview - U.S. stocks experienced gains, with the Nasdaq Composite increasing by over 100 points, the Dow up 0.06% to 46,299.96, the NASDAQ climbing 0.52% to 22,639.61, and the S&P 500 rising 0.33% to 6,666.08 [1] - Communication services shares rose by 1.6%, while health care stocks saw a slight increase of 0.1% [1] Company Performance - Abbott Laboratories' stock fell approximately 2.6% after reporting third-quarter sales of $11.37 billion, slightly below the consensus estimate of $11.40 billion [2] - The company reported adjusted earnings of $1.30, aligning with Wall Street estimates and within management's guidance of $1.28-$1.32 [2] - Abbott narrowed its fiscal 2025 adjusted earnings guidance from a range of $5.10 to $5.20 per share to $5.12 to $5.18 per share, compared to the consensus of $5.15 per share [3] Commodity Market - Oil prices increased by 0.3% to $58.89, while gold rose by 1.2% to $4,213.60 [6] - Silver traded up 1.6% to $51.405, and copper saw a slight increase of 0.1% to $5.0250 [6] Notable Stock Movements - Veritone, Inc. shares surged 68% to $9.19 following new contract wins and an updated Q3 financial outlook [9] - Genprex, Inc. experienced a significant increase of 269% to $0.9208 due to upcoming presentations at a major conference [9] - Omeros Corporation's shares rose 131% to $9.49 after Novo Nordisk acquired its global rights to Zaltenibart [9] - Yueda Digital Holding's shares plummeted 86% to $0.2001 after announcing a $28 million registered direct offering [9] - Largo Inc. shares fell 43% to $1.43 due to a $23.4 million registered direct offering and private placement [9] - Aqua Metals, Inc. shares decreased by 39% to $18.11 after raising $13 million for growth initiatives [9] Economic Indicators - The NY Empire State Manufacturing Index increased by 19.4 points to a reading of 10.7 in October, surpassing market expectations of -1.0 [11]
Gold Gains Over 1%; Abbott Shares Fall After Q3 Results - Abbott Laboratories (NYSE:ABT), Aqua Metals (NASDAQ:AQMS)